C
Carisma Therapeutics, Inc. (CARM)
PNK – Real vaqt narxi. Valyuta: USD
0.00
+0.00 (50.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
PNK – Real vaqt narxi. Valyuta: USD
0.00
+0.00 (50.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Carisma Therapeutics, Inc., biotexnologiya kompaniyasi, Qo'shma Shtatlarda jigar fibrozini va saratonni davolash uchun transformatsion terapiyalarni ishlab chiqishga qaratilgan. Uning mahsulot nomzodi CT-2401 ni o'z ichiga oladi, bu jigar fibrozini davolash uchun preklinik sinovdan o'tmoqda. Kompaniya, shuningdek, CT-1119 ni ishlab chiqmoqda, bu mezoelinni nishonga olgan CAR-Monotsit bo'lib, ilg'or mezoelin-pozitiv qattiq o'smalar, jumladan oshqozon osti bezi saratoni, tuxumdon saratoni, o'pka saratoni, mezotelioma va boshqalarni davolash uchun I bosqich klinik sinovida. Bundan tashqari, u gepatotsellyulyar karsinoma kabi qattiq o'smalarni davolash uchun in vivo CAR-M hujayra terapiyasini ishlab chiqadi. Carisma Therapeutics, Inc. onkologiya gen terapiyalarini ishlab chiqish uchun ModernaTX, Inc. bilan hamkorlik va litsenziyalash shartnomasiga ega. Kompaniya ilgari CARMA Therapeutics Inc. nomi bilan tanilgan va 2017 yil may oyida Carisma Therapeutics, Inc. ga o'zgartirilgan. Carisma Therapeutics, Inc. 2016 yilda tashkil etilgan va uning shtab-kvartirasi Filadelfiya, Pensilvaniya shtatida joylashgan.
There is no data to display
| Sana | Turi | Hujjat |
|---|---|---|
| 2025-12-29 | 15-12G | tm2534191d1_1512g.htm |
| 2025-12-15 | POS AM | tm2533416d5_posam.htm |
| 2025-12-15 | 25 | tm2533416d1_25.htm |
| 2025-12-05 | 8-K | tm2532811d1_8k.htm |
| 2025-11-12 | 10-Q | tmb-20250930x10q.htm |
| 2025-10-15 | 8-K | tm2528741d1_8k.htm |
| 2025-10-09 | 8-K | tm2528458d1_8k.htm |
| 2025-09-18 | 8-K | tm2526076d1_8k.htm |
| 2025-08-29 | 8-K | tm2524685d1_8k.htm |
| 2025-08-29 | 425 | tm2524685d2_425.htm |